Stem cell therapy performed on babies in the womb could reverse brain abnormalities linked to a severe birth defect, experts ...

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...

Six pregnant women participated in a small trial in which placenta-derived stem cells were applied to fetal spinal cords and the treatment was found to be safe.

A Phase I clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery ...

The stem cell therapy market size is expected to be worth USD 59.70 billion by 2035, increasing from USD 18.13 billion in ...

Founder, Chief Science Officer and Executive Chairman, Longeveron MIAMI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc.

Stem cell therapy performed while babies are still in the womb could help reverse brain abnormalities associated with a ...

Technological advances and growing investments in stem cell research by private entities and governments enhance therapeutic ...

Chinese scientists have achieved the world’s first reversal of type-2 diabetes using stem-cell therapy. This is no mean feat, ...

Combining stem cell therapy with standard foetal surgery before birth is a safe and promising approach to treat a severe form ...

Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need ...

Gallant, an animal health biotechnology company pioneering off-the-shelf stem cell therapies for pets, today announced a landmark fulfillment agreement with MWI Animal Health (MWI), part of global ...